Now available PAVBLU™

PAVBLU™ (aflibercept-ayyh) injection, for intravitreal use, is a vascular endothelial growth factor (VEGF) inhibitor
indicated for the treatment of patients with:

• Neovascular (Wet) Age-Related Macular Degeneration (AMD)
• Macular Edema Following Retinal Vein Occlusion (RVO)
• Diabetic Macular Edema (DME)
• Diabetic Retinopathy (DR)

View full prescribing information.